Successful use of the interleukin-17A inhibitor (ixekizumab) in the treatment of psoriatic arthritis

by A. M. Dadalova, E. A. Vasilenko, R. R. Samigullina, V. I. Mazurov
Published 2020-11-01

Pathogenetic significance of the use of a humanized monoclonal antibody to the IL-6-α receptor (tocilizumab) in the treatment of immuno-inflammatory diseases

by V. I. Mazurov, I. B. Belyaeva, R. R. Samigullina, A. L. Chudinov, A. M. Dadalova
Published 2020-07-01